invesco ltd. - IVZ
IVZ
Close Chg Chg %
26.83 0.77 2.85%
Closed Market
27.60
+0.77 (2.85%)
Volume: 4.88M
Last Updated:
May 8, 2026, 3:59 PM EDT
Company Overview: invesco ltd. - IVZ
IVZ Key Data
| Open $27.10 | Day Range 26.79 - 27.62 |
| 52 Week Range 14.10 - 29.61 | Market Cap $11.89B |
| Shares Outstanding 443.30M | Public Float 439.83M |
| Beta 1.57 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$1.48 |
| Yield 313.08% | Dividend $0.22 |
| EX-DIVIDEND DATE May 15, 2026 | SHORT INTEREST N/A |
| AVERAGE VOLUME 6.13M |
IVZ Performance
| 1 Week | 6.57% | ||
| 1 Month | 17.01% | ||
| 3 Months | 4.03% | ||
| 1 Year | 86.04% | ||
| 5 Years | -1.32% |
IVZ Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
14
Full Ratings ➔
An error occurred while fetching the data.
An error occurred while fetching the data.
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 28.773 | |
| Number of Ratings | 14 | Current Quarters Estimate | 0.612 | |
| FY Report Date | 06 / 2026 | Current Year's Estimate | 2.571 | |
| Last Quarter’s Earnings | 0.57 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | 2.03 | Next Fiscal Year Estimate | 2.944 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 10 | 10 | 12 | 12 |
| Mean Estimate | 0.61 | 0.67 | 2.57 | 2.94 |
| High Estimates | 0.66 | 0.71 | 2.72 | 3.23 |
| Low Estimate | 0.57 | 0.64 | 2.47 | 2.74 |
| Coefficient of Variance | 4.24 | 3.60 | 3.29 | 4.35 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 4 | 4 | 5 |
| OVERWEIGHT | 1 | 1 | 1 |
| HOLD | 9 | 9 | 8 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Invesco Ltd. - IVZ
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Invesco Ltd. - IVZ
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Feb 11, 2026 | Tony Lik Wong Senior Managing Director | 112,870 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $26.82 per share | 3,027,173.40 |
| Sep 26, 2025 | Markham Hunt Broyhill | 61,569 | Open market or private purchase of non-derivative security Non-derivative transaction at $20.46 per share | 1,259,701.74 |
| Sep 26, 2025 | Markham Hunt Broyhill | 62,169 | Open market or private purchase of non-derivative security Non-derivative transaction at $20.46 per share | 1,271,977.74 |
| May 20, 2025 | Thomas P. Gibbons Director | 39,090 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | William Francis Glavin Director | 72,972 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | G. Richard Wagoner Director | 99,758 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Phoebe A. Wood Director | 101,999 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Christopher C. Womack Director | 51,805 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Thomas Michael Finke Director | 56,126 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Sarah Jones Beshar Director | 107,035 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Nigel Elton Sheinwald Director | 93,856 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Elizabeth S. Johnson Director | 40,658 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| May 20, 2025 | Paula C. Tolliver Director | 58,161 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
Invesco Ltd. in the News
Democratic tax proposal takes aim at ETFs
A top Senate Democrat has been circulating a proposal that would hit the rapidly growing world of exchange-traded funds. Big money managers are bracing for a fight.